1-4 of 4
Hani M. Babiker
Close
Sort by
Journal Articles

Retrospective Real-World Analysis of the Primary Safety Outcomes in Venous Thromboembolism of High-Risk Major Bleeding Cancer Patients Receiving Therapeutic Anticoagulation

Eric Brucks Brucks, MD, Sumana Veeravelli, MD, Ritika Halder, MD, Francisco Javier Martinez, MD, Jorge Andres Leiva, Kathylynn Saboda, MS, Denise Roe, DrPH, Hani M. Babiker, MD, Ali McBride, Alejandro Recio-Boiles, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-139641
Published: 2020
Journal Articles

Recurrent Venous Thromboembolism (VTE), Major Bleeding (MB), and Associated Cost of Treatment with Low Molecular Weight Heparin (LMWH) or Direct Oral Anticoagulant (DOAC) in High Risk Patients with Gastrointestinal (GI) Malignancies: Retrospective Real-World Analysis at a Comprehensive Cancer Center

Alejandro Recio Boiles, MD, Ali McBride, PharmD,MS, Hani M. Babiker, MD, Nimer Alsaid, PhD MS, PharmD, Ivo Abraham, PhD RN, Emad Elquza, MD MBA
Journal: Blood
Blood (2018) 132 (Supplement 1): 5057.
https://doi.org/10.1182/blood-2018-99-114204
Published: 2018
Journal Articles

Clinical Risk Factors Associated with Recurrent Venous Thromboembolism and Major Bleeding in Gastrointestinal Cancer Patients Receiving Doacs for Secondary Thromboprophylaxis

Alejandro Recio Boiles, MD, Jessica Vondrak, MD, Kristopher J. Abbate, AB, Hani M. Babiker, MD, Aaron J. Scott, MD, Ali McBride, PharmD, MS, BCPS, BCOP, Emad Elquza, MD MBA
Journal: Blood
Blood (2017) 130 (Supplement 1): 4918.
https://doi.org/10.1182/blood.V130.Suppl_1.4918.4918
Published: 2017
Journal Articles

Basophilic blast phase of chronic myelogenous leukemia

Hani M. Babiker, Maria Proytcheva
Journal: Blood
Blood (2014) 124 (15): 2464.
https://doi.org/10.1182/blood-2014-08-593194
Published: 2014